Literature DB >> 21146170

Sulfation of 25-hydroxycholesterol by SULT2B1b decreases cellular lipids via the LXR/SREBP-1c signaling pathway in human aortic endothelial cells.

Qianming Bai1, Leyuan Xu, Genta Kakiyama, Melissa Ann Runge-Morris, Phillip B Hylemon, Lianhua Yin, William M Pandak, Shunlin Ren.   

Abstract

OBJECTIVE: 25-Hydroxycholesterol (25HC) and its sulfated metabolite, 25-hydroxycholesterol-3-sulfate (25HC3S), regulate certain aspects of lipid metabolism in opposite ways. Hence, the enzyme for the biosynthesis of 25HC3S, oxysterol sulfotransferase (SULT2B1b), may play a crucial role in regulating lipid metabolism. We evaluate the effect of 25HC sulfation on lipid metabolism by overexpressing the gene encoding SULT2B1b in human aortic endothelial cells (HAECs) in culture. METHODS AND
RESULTS: The human SULT2B1b gene was successfully overexpressed in HAECs following infection using a recombinant adenovirus. HPLC analysis demonstrated that more than 50% of (3)H-25HC was sulfated in 24h following overexpression of the SULT2B1b gene. In the presence of 25HC, SULT2B1b overexpression significantly decreased mRNA and protein levels of LXR, ABCA1, SREBP-1c, ACC-1, and FAS, which are key regulators of lipid biosynthesis and transport; and subsequently reduced cellular lipid levels. Overexpression of the gene encoding SULT2B1b gave similar results as adding exogenous 25HC3S. However, in the absence of 25HC or in the presence of T0901317, synthetic liver oxysterol receptor (LXR) agonist, SULT2B1b overexpression had no effect on the regulation of key genes involved in lipid metabolism.
CONCLUSIONS: Our data indicate that sulfation of 25HC by SULT2B1b plays an important role in the maintenance of intracellular lipid homeostasis via the LXR/SREBP-1c signaling pathway in HAECs.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21146170      PMCID: PMC3031658          DOI: 10.1016/j.atherosclerosis.2010.11.021

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  31 in total

1.  Expression of sterol 12alpha-hydroxylase alters bile acid pool composition in primary rat hepatocytes and in vivo.

Authors:  W M Pandak; P Bohdan; C Franklund; D H Mallonee; G Eggertsen; I Björkhem; G Gil; Z R Vlahcevic; P B Hylemon
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

Review 2.  The role of orphan nuclear receptors in the regulation of cholesterol homeostasis.

Authors:  J J Repa; D J Mangelsdorf
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

3.  Biosynthesis of the regulatory oxysterol, 5-cholesten-3beta,25-diol 3-sulfate, in hepatocytes.

Authors:  Xiaobo Li; William M Pandak; Sandra K Erickson; Yongjie Ma; Lianhua Yin; Phillip Hylemon; Shunlin Ren
Journal:  J Lipid Res       Date:  2007-09-21       Impact factor: 5.922

4.  Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression.

Authors:  Brandee L Wagner; Annabel F Valledor; Gang Shao; Chris L Daige; Eric D Bischoff; Mary Petrowski; Kristen Jepsen; Sung Hee Baek; Richard A Heyman; Michael G Rosenfeld; Ira G Schulman; Christopher K Glass
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

5.  SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis.

Authors:  X Wang; R Sato; M S Brown; X Hua; J L Goldstein
Journal:  Cell       Date:  1994-04-08       Impact factor: 41.582

6.  Overexpression of mitochondrial cholesterol delivery protein, StAR, decreases intracellular lipids and inflammatory factors secretion in macrophages.

Authors:  Yanxia Ning; Qianming Bai; Hong Lu; Xiaobo Li; William M Pandak; Fengdi Zhao; Sifeng Chen; Shunlin Ren; Lianhua Yin
Journal:  Atherosclerosis       Date:  2008-09-13       Impact factor: 5.162

7.  Hormonal regulation of cholesterol 7 alpha-hydroxylase mRNA levels and transcriptional activity in primary rat hepatocyte cultures.

Authors:  P B Hylemon; E C Gurley; R T Stravitz; J S Litz; W M Pandak; J Y Chiang; Z R Vlahcevic
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

8.  24-hydroxycholesterol sulfation by human cytosolic sulfotransferases: formation of monosulfates and disulfates, molecular modeling, sulfatase sensitivity, and inhibition of liver x receptor activation.

Authors:  Ian T Cook; Zofia Duniec-Dmuchowski; Thomas A Kocarek; Melissa Runge-Morris; Charles N Falany
Journal:  Drug Metab Dispos       Date:  2009-07-09       Impact factor: 3.922

9.  Sulfated oxysterol, 25HC3S, is a potent regulator of lipid metabolism in human hepatocytes.

Authors:  Shunlin Ren; Xiaobo Li; Daniel Rodriguez-Agudo; Gregorio Gil; Phillip Hylemon; William M Pandak
Journal:  Biochem Biophys Res Commun       Date:  2007-07-06       Impact factor: 3.575

Review 10.  Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses.

Authors:  Laurent Yvan-Charvet; Nan Wang; Alan R Tall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10-01       Impact factor: 8.311

View more
  33 in total

1.  Hydroxysteroid sulfotransferase 2B1b expression and localization in normal human brain.

Authors:  Emily D Salman; Ona Faye-Petersen; Charles N Falany
Journal:  Horm Mol Biol Clin Investig       Date:  2011-10

2.  25-Hydroxycholesterol-3-sulfate attenuates inflammatory response via PPARγ signaling in human THP-1 macrophages.

Authors:  Leyuan Xu; Shanwei Shen; Yongjie Ma; Jin Koung Kim; Daniel Rodriguez-Agudo; Douglas M Heuman; Phillip B Hylemon; William M Pandak; Shunlin Ren
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-01-24       Impact factor: 4.310

Review 3.  Structure, dynamics and selectivity in the sulfotransferase family.

Authors:  Thomas S Leyh; Ian Cook; Ting Wang
Journal:  Drug Metab Rev       Date:  2013-09-11       Impact factor: 4.518

4.  Testing the sulfotransferase molecular pore hypothesis.

Authors:  Ian Cook; Ting Wang; Steven C Almo; Jungwook Kim; Charles N Falany; Thomas S Leyh
Journal:  J Biol Chem       Date:  2013-01-28       Impact factor: 5.157

5.  An Unexpected Role of Cholesterol Sulfotransferase and its Regulation in Sensitizing Mice to Acetaminophen-Induced Liver Injury.

Authors:  Yunqi An; Pengcheng Wang; Pengfei Xu; Hung-Chun Tung; Yang Xie; Levent Kirisci; Meishu Xu; Songrong Ren; Xin Tian; Xiaochao Ma; Wen Xie
Journal:  Mol Pharmacol       Date:  2019-04-03       Impact factor: 4.436

Review 6.  Role of Liver X Receptor in Mastitis Therapy and Regulation of Milk Fat Synthesis.

Authors:  Xiaoyu Hu; Naisheng Zhang; Yunhe Fu
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-07-31       Impact factor: 2.673

7.  6-Ketocholestanol suppresses lipid accumulation by decreasing FASN gene expression through SREBP-dependent regulation in HepG2 cells.

Authors:  Bungo Shirouchi; Shuhei Yanagi; Chinami Okawa; Maiko Koga; Masao Sato
Journal:  Cytotechnology       Date:  2020-01-13       Impact factor: 2.058

8.  The gate that governs sulfotransferase selectivity.

Authors:  Ian Cook; Ting Wang; Steven C Almo; Jungwook Kim; Charles N Falany; Thomas S Leyh
Journal:  Biochemistry       Date:  2012-12-28       Impact factor: 3.162

9.  5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse model.

Authors:  Leyuan Xu; Jin Koung Kim; Qianming Bai; Xin Zhang; Genta Kakiyama; Hae-Ki Min; Arun J Sanyal; William M Pandak; Shunlin Ren
Journal:  Mol Pharmacol       Date:  2012-12-20       Impact factor: 4.436

10.  Cholesterol Sulfonation Enzyme, SULT2B1b, Modulates AR and Cell Growth Properties in Prostate Cancer.

Authors:  Renee E Vickman; Scott A Crist; Kevin Kerian; Livia Eberlin; R Graham Cooks; Grant N Burcham; Kimberly K Buhman; Chang-Deng Hu; Andrew D Mesecar; Liang Cheng; Timothy L Ratliff
Journal:  Mol Cancer Res       Date:  2016-06-24       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.